Skip to main content

Sagimet Biosciences Inc.

For the period ended Jun 5, 2024. Filed Apr 18, 2024.

View on SEC.gov

About this filing

What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.

Jun 5, 2024 · Filed Apr 18, 2024

SGMT$9.85+8.0%Stored close · as of Nov 6, 2026
See the whole filing, with its images and exhibits

AVAILABILITY OF MATERIALS

​

AVAILABILITY OF MATERIALS

Our 2023 Annual Report, including the financial statements and financial statement schedules, has been filed with the SEC and provides additional information about us, which is incorporated by reference herein. It is available on the internet at www.sagimet.com and is available in paper form (other than exhibits thereto) by first class mail or other equally prompt means to beneficial owners of our Series A common stock, without charge, upon written request to: General Counsel, Sagimet Biosciences Inc., 155 Bovet Road, Suite 303, San Mateo, California 94402. In addition, it is available to beneficial and record holders of our Series A common stock at www.astproxyportal.com/ast/24419.

SAGIMETANNUALMEETINGBIOSCIENCESOFSTOCKHOLDROFINC.June 5, 2024PROXY VOTING INSTRUCTIONSINTERNET - Access “www.voteproxy.com” and follow the on-screeninstructions or scan the QR code with your smartphone. Have your proxycard available when you access the web page.TELEPHONE - Call toll-free 1-800-PROXIES (1-800-776-9437) inthe United States or 1-201-299-4446 from foreign countries from anytouch-tone telephone and follow the instructions. Have your proxy cardavailable when you call.Vote online/phone until 11:59 PM EST the day before the meeting.MAIL - Sign, date and mail your proxy card in the envelope provided asCOMPANY NUMBERsoon as possible.VIRTUALLY AT THE MEETING - The company will be hosting the meetinglive via the Internet. To attend the meeting via the Internet, please visitACCOUNT NUMBERhttps://web.lumiconnect.com/217605655 (password: sagimet2024) andbe sure to have your control number available.GO GREEN - e-Consent makes it easy to gopaperless. Withe-Consent, you can quickly access yourproxy materials,statements and other eligible documents online, while reducing costs,clutter and paper waste. Enroll today via https://equiniti.com/us/ast-accessto enjoy online access. Please detach along perforated line and mail in the envelope provided IF you are not voting via telephone or the Internet. 20230000000000001000 9060524THE BOARD OF DIRECTORS RECOMMENDS A VOTE "FOR" THE ELECTION OF EACH CLASS I DIRECTOR NOMINEE AND "FOR" PROPOSAL 2.PLEASE SIGN, DATE AND RETURN PROMPTLY IN THE ENCLOSED ENVELOPE. PLEASE MARK YOUR VOTE IN BLUE OR BLACK INK AS SHOWN HERE x1. The election of Class I directors for a three year term expiring in 2027:2. The ratification of the appointment of Deloitte & Touche LLP as the FOR AGAINST ABSTAINNOMINEES:independent registered public accounting firm for the fiscal yearending December 31, 2024.FOR ALL NOMINEESO Paul HoelscherWITHHOLD AUTHORITYO Timothy P. WalbertFOR ALL NOMINEESIn their discretion, the proxies are authorized to vote upon such other business as mayFOR ALL EXCEPTproperly come before the Annual Meeting. This proxy when properly executed will be votedas directed herein by the undersigned shareholder. If no direction is made, this proxy(See instructions below)will be voted FOR ALL NOMINEES in Proposal 1 and FOR Proposal 2.INSTRUCTIONS: To withhold authority to vote for any individual nominee(s), mark “FOR ALL EXCEPT” and fill in the circle next to each nominee you wish to withhold, as shown here: MARK“X” HERE IF YOU PLAN TO ATTEND THE MEETING.To change the address on your account, please check the box at right andindicate your new address in the address space above. Please note thatchanges to the registered name(s) on the account may not be submitted viathis method. Signature of StockholderDate:Signature of StockholderDate:Note: Please signexactly as your name or names appear on this Proxy. Whensharesare held jointly, eachholder should sign. Whensigning as executor, administrator, attorney, trustee orguardian,please give fulltitle as such. If the signer is a corporation, please sign full corporate name by duly authorized officer, giving full title as such. If signer is a partnership, please sign in partnership name by authorized person.

SAGIMET BIOSCIENCES INC.155 Bovet Road, Suite 303San Mateo, California 94402THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORSThe undersigned stockholder hereby appoints David Happel and Elizabeth Rozek as proxies, each with full power of substitution, to represent and vote as designated on the reverse side of this ballot, all the shares of Series A Common Stock of Sagimet Biosciences Inc. held of record and entitled to vote by the undersigned as of April 10, 2024, at the AnnualMeeting of Stockholders to be held on Wednesday June 5, 2024, at 10:00 a.m. Pacific Time, and at, or any adjournment or postponement thereof, as well as to vote upon such other business as may properly come before the Annual Meeting of Stockholders.(Continued and to be signed on the reverse side)1.114475

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.